Generic Drug News and Research

RSS
Generic Drugs are official nonbrand names by which medicines are known. Generic names usually refer to the chemical name of the drug.
Researchers announce new method to build important heparin drug

Researchers announce new method to build important heparin drug

Preclinical data from Teva's COPAXONE study on multiple sclerosis

Preclinical data from Teva's COPAXONE study on multiple sclerosis

Oral laquinimod shows promise against multiple sclerosis

Oral laquinimod shows promise against multiple sclerosis

Viewpoints: 'Killing' Medicaid; medicine for mentally ill; 'outrageous' veto of mammogram bill in Calif.

Viewpoints: 'Killing' Medicaid; medicine for mentally ill; 'outrageous' veto of mammogram bill in Calif.

Teva acquires Cephalon

Teva acquires Cephalon

COPAXONE reduces loss of brain volume in patients with RRMS

COPAXONE reduces loss of brain volume in patients with RRMS

Research roundup: Health disparities; Prescription drug abuse in Medicare Part D; Medicaid's role for HIV patients

Research roundup: Health disparities; Prescription drug abuse in Medicare Part D; Medicaid's role for HIV patients

Drug combo for breast cancer in post-menopausal women shows promise

Drug combo for breast cancer in post-menopausal women shows promise

New York Times examines possible entry into global market of generic drugs for NCDs

New York Times examines possible entry into global market of generic drugs for NCDs

Teva to invest in CDI for development of novel antiviral drugs

Teva to invest in CDI for development of novel antiviral drugs

Synthon announces European approvals for Eplerenone

Synthon announces European approvals for Eplerenone

Top-line results from Teva-Alcobra MG01CI Phase II trial for ADHD

Top-line results from Teva-Alcobra MG01CI Phase II trial for ADHD

Cost of second-line ARVs a 'huge barrier to care' in resource-poor countries

Cost of second-line ARVs a 'huge barrier to care' in resource-poor countries

First Edition: August 26, 2011

First Edition: August 26, 2011

Viewpoints: WSJ on 'super committee'; NEJM perspectives on medical devices

Viewpoints: WSJ on 'super committee'; NEJM perspectives on medical devices

FDA accepts Teva's NDA for BDP Nasal HFA to treat allergic rhinitis

FDA accepts Teva's NDA for BDP Nasal HFA to treat allergic rhinitis

Medicare prescriptions premiums expected to decrease for seniors

Medicare prescriptions premiums expected to decrease for seniors

Par Pharmaceutical reports second quarter total revenues of $224.2 million

Par Pharmaceutical reports second quarter total revenues of $224.2 million

Teva's ZOELY oral contraceptive receives EU Marketing Authorization

Teva's ZOELY oral contraceptive receives EU Marketing Authorization

Dr. Reddy's, FUJIFILM sign MoU to enter partnership in the generic drugs business

Dr. Reddy's, FUJIFILM sign MoU to enter partnership in the generic drugs business